# Somerville Acquisitions, Inc. – FDA Inspection, Dec 3, 2013

Source: https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/7279acf7-3f2c-4eed-ad4d-f87e1934e500
Source feed: FDA_Inspections

> FDA inspection 857121 of Somerville Acquisitions, Inc., December 03, 2013. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 857121
- Company Name: Somerville Acquisitions, Inc.
- Inspection Date: 2013-12-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1272925 - 2025-06-04](https://www.keypedia.com/records/fda_inspections/somerville-acquisitions-inc/c35ab5e9-f2f1-4af1-aa02-290fa8dcfddc)
- FDA Inspection 1120564 - 2020-01-30
- FDA Inspection 739753 - 2011-08-15
- FDA Inspection 646902 - 2010-02-16

Company: https://www.keypedia.com/companies/somerville-acquisitions-inc/195f0557-96af-4562-98e7-9e03150b33cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c